TriRx: new facility in Segré, France
CDMO TriRX has completed the purchase of a facility in Segré, a former Merck-owned plant. The FDA and EU GMP-compliant site is located in a major biopharmaceutical hub, easily accessible from nearby Angers and Paris.
The biopharmaceutical manufacturing facility is situated on a 30,000-square-meter site. Capabilities include sterile and non-sterile manufacturing, filling and packaging; solutions, suspensions and ointments; aseptic compounding; non-sterile filling in small and large bottles; non-sterile compounding of liquids and ointments; and more.
